Periadventitial angiopoietin-1 gene transfer induces angiogenesis in rabbit carotid arteries

被引:0
作者
S Bhardwaj
H Roy
T Kärpänen
Y Hi
S Jauhiainen
M Hedman
K Alitalo
S Ylä-Herttuala
机构
[1] University of Kuopio,Department of Biotechnology and Molecular Medicine, A.I.Virtanen Institute for Molecular Sciences
[2] University of Helsinki,Molecular/Cancer Biology Laboratory, Haartman Institute
[3] University of Kuopio,Department of Medicine
[4] Kuopio University Hospital,Gene Therapy Unit
来源
Gene Therapy | 2005年 / 12卷
关键词
angiopoietins; angiogenesis; neovessels; VEGF receptor-1-Ig;
D O I
暂无
中图分类号
学科分类号
摘要
This study was performed to evaluate angiogenic responses of angiopoietin-1 (Ang1) in vivo after adenovirus-mediated gene transfer in the periadventitial space of the rabbit carotid arteries using a collar technique. Adenoviruses encoding LacZ and vascular endothelial growth factor (VEGF) receptor-1-Ig fusion protein (VEGF-R1-Ig) adenoviruses were used as controls. Increased neovessel formation was seen in adventitia of the Ang1 transduced arteries 7 days after the gene transfer. Neovessels in the Ang1 transduced arteries were large in size and well perfused. Ang1 binds to Tie2 (tyrosine kinase with immunoglobulin and epidermal growth factor homology domain) receptors, which were expressed in the endothelium of the neovessels. When VEGF-R1-Ig was used with Ang1, it resulted in a decrease in the number of neovessels, which implies that VEGF-A or some other VEGF-R1 ligand(s) play a crucial role in angiogenesis occurring in response to Ang1. There were no significant differences in the total number of capillaries in the adventitia of the VEGF-R1-Ig transduced arteries as compared to LacZ controls. Neointima formation was not increased in the Ang1 transduced arteries as compared to the controls. We conclude that in the periadventitial space Ang1 shows angiogenic activity and is a potentially useful factor for the induction of therapeutic vascular growth in vivo.
引用
收藏
页码:388 / 394
页数:6
相关论文
共 55 条
  • [31] Shyu KG(2003)Angiopoietin-1 inhibits vascular permeability, angiogenesis, and growth of hepatic colon cancer tumors FASEB J 17 100-102
  • [32] Baffert F(2001)Angiogenesis-dependent and independent phases of intimal hyperplasia Circ Res 89 477-479
  • [33] Gruchala M(2003)Angiopoietin-1 protects against the development of cardiac allograft arteriosclerosis Br J Pharmacol 139 329-336
  • [34] Roy H(2003)Fibroblast growth factor 4 induces vascular permeability, angiogenesis and arteriogenesis in a rabbit hindlimb ischemia model Circ Res 92 1098-1106
  • [35] Bhardwaj S(1993)Angiopoietin-1 reduces VEGF-stimulated leukocyte adhesion to endothelial cells by reducing ICAM-1, VCAM-1, and E-selectin expression Oncogene 8 2931-2937
  • [36] Yla-Herttuala S(1999)Angiopoietin-1 inhibits endothelial permeability, neutrophil adherence and IL-8 production Blood 93 1253-1263
  • [37] Ylä-Herttuala S(2002)VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses Mol Ther 6 127-133
  • [38] Alitalo K(undefined)Two human FLT4 receptor tyrosine kinase isoforms with distinct carboxy terminal tails are produced by alternative processing of primary transcripts undefined undefined undefined-undefined
  • [39] Minamikawa T(undefined)Maturation of embryonic stem cells into endothelial cells in an undefined undefined undefined-undefined
  • [40] Miyake T(undefined) model of vasculogenesis undefined undefined undefined-undefined